Talks
The Next Five Years in Myeloma
October 26, 2026
Closing Access Gaps in Myeloma Care
October 26, 2026
What Does Cure Mean to Patients?
October 26, 2026
Managing Infection Risk With Bispecifics
October 26, 2026
Optimizing Bispecific Dosing
October 26, 2026
CAR-T and Bispecifics: Trials vs. Practice
October 26, 2026
Redefining High-Risk Myeloma
October 26, 2026
Rethinking Transplant and Maintenance
October 26, 2026
What Stood Out at IMS 2026?
October 26, 2026
The Challenge of Rechallenge
October 26, 2026
Close button
Why are you reporting this TALK?